LEUKEMIA, JUVENILE MYELOMONOCYTIC

Clinical trials for LEUKEMIA, JUVENILE MYELOMONOCYTIC explained in plain language.

Never miss a new study

Get alerted when new LEUKEMIA, JUVENILE MYELOMONOCYTIC trials appear

Sign up with your email to follow new studies for LEUKEMIA, JUVENILE MYELOMONOCYTIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New hope for kids with rare leukemia: targeted drug combo enters trial

Disease control Recruiting now

This study tests a new treatment plan for children with juvenile myelomonocytic leukemia (JMML), a rare blood cancer. Lower-risk patients receive two drugs (trametinib and azacitidine), while higher-risk patients get those plus chemotherapy. The goal is to see if the combinations…

Matched conditions: LEUKEMIA, JUVENILE MYELOMONOCYTIC

Phase: PHASE1, PHASE2 • Sponsor: Therapeutic Advances in Childhood Leukemia Consortium • Aim: Disease control

Last updated May 26, 2026 12:12 UTC

LEUKEMIA, JUVENILE MYELOMONOCYTIC

Get alerted when new LEUKEMIA, JUVENILE MYELOMONOCYTIC trials appear

New hope for kids with rare leukemia: targeted drug combo enters trial